Chicken ovalbumin upstream promoter transcription factor II in human breast carcinoma: Possible regulator of lymphangiogenesis via vascular endothelial growth factor-C expression

Cancer Science

Volumn 100, Issue 4, 2009, Pages 639-645

  Nagasaki, Shuji ^a,b   Suzuki, Takashi ^a   Miki, Yasuhiro ^a   Akahira, Jun Ichi ^a   Shibata, Hirotaka ^c   Ishida, Takanori ^a   Ohuchi, Noriaki ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Grelan Pharmaceutical Co Ltd   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; MESSENGER RNA; PROGESTERONE RECEPTOR; SMALL INTERFERING RNA; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CELL LINE; DISEASE FREE SURVIVAL; FEMALE; GENE ACTIVITY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SURVIVAL TIME; TUMOR VOLUME; BREAST TUMOR; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MIDDLE AGED; TUMOR CELL LINE;

ADULT; AGED; BREAST NEOPLASMS; CELL LINE, TUMOR; COUP TRANSCRIPTION FACTOR II; ESTROGEN RECEPTOR ALPHA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LYMPHANGIOGENESIS; MIDDLE AGED; RNA, MESSENGER; RNA, SMALL INTERFERING; VASCULAR ENDOTHELIAL GROWTH FACTOR C; YOUNG ADULT;

EID: 67449093629     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01078.x     Document Type: Article

References (28)

1. Tsai SY, Tsai MJ. Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): Coming of age. Endocr Rev 1997; 18: 229-40.
2. Sagami I, Tsai SY, Wang H, Tsai MJ, O'Malley BW. Identification of two factors required for transcription of the ovalbumin gene. Mol Cell Biol 1986; 6: 4259-67.
3. Wang LH, Tsai SY, Sagami I, Tsai MJ, O'Malley BW. Purification and characterization of chicken ovalbumin upstream promoter transcription factor from HeLa cells. J Biol Chem 1987; 262: 16 080-6.
4. Park JI, Tsai SY, Tsai MJ. Molecular mechanism of chicken ovalbumin upstream promoter-transcription factor (COUP-TF) actions. Keio J Med 2003; 52: 174-81.
5. Cooney AJ, Leng X, Tsai SY, O'Malley BW, Tsai MJ. Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone, and retinoic acid receptors. J Biol Chem 1993; 268: 4152-60.
6. Kliewer SA, Umesono K, Heyman RA, Mangelsdorf DJ, Dyck JA, Evans RM. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 1992; 89: 1448-52.
7. Wang LH, Ing NH, Tsai SY, O'Malley BW, Tsai MJ. The COUP-TFs compose a family of functionally related transcription factors. Gene Expr 1991; 1: 207-16.
8. Metivier R, Gay FA, Hubner MR et al. Formation of an hER alpha-COUP-TFI complex enhances hER alpha AF-1 through Ser118 phosphorylation by MAPK. EMBO J 2002; 21: 3443-53.
9. Le Dily F, Metivier R, Gueguen MM et al. COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells. Breast Cancer Res Treat 2008; 110: 69-83.
10. Navab R, Gonzalez-Santos JM, Johnston MR et al. Expression of chicken ovalbumin upstream promoter-transcription factor II enhances invasiveness of human lung carcinoma cells. Cancer Res 2004; 64: 5097-105.
11. Kieback DG, Levi T, Kohlberger P et al. Chicken ovalbumin upstream promoter-transcription factor (COUP-TF) expression in human endometrial cancer cell lines. Anticancer Res 1996; 16: 3371-6.
12. Kieback DG, Runnebaum IB, Moebus VJ et al. Chicken ovalbumin upstream promoter transcription factor (COUP-TF): An orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines. Gynecol Oncol 1993; 51: 167-70.
13. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410
14. Suzuki T, Inoue A, Miki Y et al. Early growth responsive gene 3 in human breast carcinoma: A regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr Relat Cancer 2007; 14: 279-92.
15. Honma N, Horii R, Iwase T et al. Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J Clin Oncol 2008; 26: 3727-34.
16. Ogawa Y, Hai E, Matsumoto K et al. Androgen receptor expression in breast cancer: Relationship with clinicopathological factors and biomarkers. Int J Clin Oncol 2008; 13: 431-5.
17. Schafer G, Wissmann C, Hertel J, Lunyak V, Hocker M. Regulation of vascular endothelial growth factor D by orphan receptors hepatocyte nuclear factor-4 alpha and chicken ovalbumin upstream promoter transcription factors 1 and 2. Cancer Res 2008; 68: 457-66.
18. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2: 573-83.
19. Skobe M, Hawighorst T, Jackson DG et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-8.
20. Sun P, Gao J, Liu YL, Wei LW, Wu LP, Liu ZY. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells. Mol Cell Biochem 2008; 308: 161-8.
21. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 1999; 13: 1037-49.
22. Pereira FA, Qiu Y, Tsai MJ, Tsai SY. Chicken ovalbumin upstream promoter transcription factor (COUP-TF): Expression during mouse embryogenesis. J Steroid Biochem Mol Biol 1995; 53: 503-8.
23. Suzuki T, Moriya T, Darnel AD, Takeyama J, Sasano H. Immunohistochemical distribution of chicken ovalbumin upstream promoter transcription factor II in human tissues. Mol Cell Endocrinol 2000; 164: 69-75.
24. Riggs KA, Wickramasinghe NS, Cochrum RK, Watts MB, Klinge CM. Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells. Cancer Res 2006; 66: 10 188-98.
25. Pentheroudakis G, Kalogeras KT, Wirtz RM et al. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: A quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial. Breast Cancer Res Treat 2008. Available from URL: http://www.springerlink.com/content/t56x2545068w4320/.
26. More E, Fellner T, Doppelmayr H et al. Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines. J Endocrinol 2003; 176: 83-94.
27. Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: From traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat 2006; 95: 211-18.
28. Nakshatri H, Mendonca MS, Bhat-Nakshatri P, Patel NM, Goulet RJ Jr, Cornetta K. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21 (WAF1/ CIP1), cyclin D1, and cdk2. Biochem Biophys Res Commun 2000; 270: 1144-53.